Normalization of Preexposure Prophylaxis for Adolescents: Empowerment, Not Vulnerability
JAMA Pediatr
.
2020 Dec 1;174(12):1133-1134.
doi: 10.1001/jamapediatrics.2020.2545.
Authors
Jessica Londeree Saleska
1
,
Sung-Jae Lee
1
2
Affiliations
1
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles.
2
Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles.
PMID:
32804198
PMCID:
PMC8302259
DOI:
10.1001/jamapediatrics.2020.2545
No abstract available
Publication types
Review
MeSH terms
Adolescent
Anti-HIV Agents / therapeutic use*
HIV Infections / prevention & control*
HIV*
Humans
Pre-Exposure Prophylaxis / standards*
Substances
Anti-HIV Agents
Grants and funding
P30 MH058107/MH/NIMH NIH HHS/United States
T32 MH109205/MH/NIMH NIH HHS/United States
U19 HD089886/HD/NICHD NIH HHS/United States